Subcutaneous furosemide in advanced heart failure: has clinical practice run ahead of the evidence base? | BMJ Supportive & Palliative Care

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article info

Editorials

Subcutaneous furosemide in advanced heart failure: has clinical practice run ahead of the evidence base?

Free

Authors

James M Beattie PubMed articles Google scholar articles
Miriam J Johnson PubMed articles Google scholar articles

Correspondence to Dr James M Beattie, Department of Cardiology, Heart of England NHS Foundation Trust, Heartlands Hospital, Bordesley Green East, Birmingham B9 5SS, UK; james.beattie{at}heartofengland.nhs.uk

Citation

Beattie JM, Johnson MJ

Subcutaneous furosemide in advanced heart failure: has clinical practice run ahead of the evidence base?

BMJ Supportive & Palliative Care 2012;2:5-6.

Publication history

Received August 9, 2011
Accepted November 9, 2011
First published November 29, 2011.

Online issue publication

April 19, 2016

Article Versions

Previous version (19 April 2016).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions